
<!DOCTYPE html>
<!--[if lt IE 8]>      <html class="no-js nav theme-blue lt-ie10 lt-ie9 lt-ie8  " lang="en-us"> <![endif]-->
<!--[if IE 8]>         <html class="no-js nav theme-blue lt-ie10 lt-ie9  " lang="en-us"> <![endif]-->
<!--[if IE 9]>         <html class="no-js nav theme-blue lt-ie10  " lang="en-us"> <![endif]-->
<!--[if !IE]><!-->     <html class="no-js nav theme-blue  " lang="en-us" > <!--<![endif]-->	
    <head>
        <meta charset="utf-8" />
                <title>Chlamydial Infections - 2015 STD Treatment Guidelines</title>
        		
        <meta name="description" content="Chlamydial Infections - 2015 STD Treatment Guidelines" />        <meta name="keywords" content="2015, treatment guidelines, treatment, STD, sexually transmitted diseases, chlamydia, STI, CDC" />		<meta name="viewport" content="width=device-width, initial-scale=1" />
		        <link rel="apple-touch-icon-precomposed" sizes="144x144" href="../../TemplatePackage/3.0/images/cdc-touch-icon-144x144.png" />
        <link rel="apple-touch-icon-precomposed" sizes="114x114" href="../../TemplatePackage/3.0/images/cdc-touch-icon-114x114.png" />
        <link rel="apple-touch-icon-precomposed" sizes="72x72" href="../../TemplatePackage/3.0/images/cdc-touch-icon-72x72.png" />
        <link rel="apple-touch-icon-precomposed" href="../../TemplatePackage/3.0/images/cdc-touch-icon-57x57.png" />
        <link rel="shortcut icon" href="../../TemplatePackage/3.0/images/favicon.ico" />	
		
		<meta name="robots" content="index,follow" />
		<meta property="cdc:template_version" content="3.0" />
		<meta property="cdc:content-id" content="709558"/>
		<meta property="cdc:revision-id" content="1"/>
				<link rel="canonical" href="http://www.cdc.gov/std/tg2015/chlamydia.htm"/>
				<!-- Internal Release Version # 3.6.3 -->
                			<link rel="stylesheet" href="../../TemplatePackage/3.0/css/lib/bootstrap24.css" />
	<link rel="stylesheet" href="../../TemplatePackage/3.0/css/app.css@3.2.1.7.css" />
	<!--[if gt IE 9]><!--><!--<![endif]-->
	<!--[if IE 7]>
		<link rel="stylesheet" href="/TemplatePackage/3.0/css/lib/font-awesome-ie7.css" />
	<![endif]-->
	<!--[if lt IE 9]>
		<link rel="stylesheet" href="/TemplatePackage/3.0/css/ie.css" />
	<![endif]-->
	<link rel="stylesheet" media="print" href="../../TemplatePackage/3.0/css/print.css@3.2.1.7.css" />
	<script src="../../TemplatePackage/3.0/js/libs/modernizr-latest.js"></script>
	<script>
		if(!Date.now){Date.now=function now(){return new Date().getTime()}}
		var page_timing = page_timing || {};
		page_timing.page_start = Date.now();
		function $$(e){if(window.$){e()}else{setTimeout(function(){$$(e)},50)}}
		// (function(){function e(e,t){var n=e.length;while(n--){if(e[n].indexOf(t)>-1){return e[n]}}return false}var t=e(document.getElementsByTagName("html")[0].className.split(" "),"theme-");if(t){var n=document.createElement("link");n.rel="stylesheet";n.type="text/css";n.media="screen";n.href="/TemplatePackage/3.0/css/themes/"+t+".css";document.getElementsByTagName("head")[0].appendChild(n)}})();

		var settings = {}, addthis = null;
	</script>

	<meta name="application-name" content="CDC.gov"/>
	<meta property="cdc:template_version" content="3.2.1.7" />
	<meta name="msapplication-TileColor" content="#0061aa" />
	<meta name="msapplication-square70x70logo" content="/TemplatePackage/3.0/images/Win8_tile_70x70.png" />
	<meta name="msapplication-square150x150logo" content="/TemplatePackage/3.0/images/Win8_tile_150x150.png" />
	<meta name="msapplication-wide310x150logo" content="/TemplatePackage/3.0/images/Win8_tile_310x150.png" />
	<meta name="msapplication-square310x310logo" content="/TemplatePackage/3.0/images/Win8_tile_310x310.png" />
	<meta name="viewport" content="width=device-width,initial-scale=1,shrink-to-fit=no">		        



                		    </head>
    <body>
				



				<div id="skipmenu">
	<a href="chlamydia.htm#searchTarget" class="skippy">Skip directly to search</a>
	<a href="chlamydia.htm#azTab" class="skippy">Skip directly to A to Z list</a>
	<a href="chlamydia.htm#nav-container" class="skippy">Skip directly to navigation</a>
	<a href="chlamydia.htm#share-bar" class="skippy">Skip directly to page options</a>
	<a href="chlamydia.htm#contentArea" class="skippy">Skip directly to site content</a>
</div>		    	<div id="wrapper">
    		
<!-- references to this removed intentionally -->
    		<header id="header">
    			<div class="container">
                    <div class="row">
                    	<div id="logo" class="span14">
                    		<!--iPad touch response and 508 voice reader issue currently under investigation -->
<a href="../../index.html" title="Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People">
	<img src="../../TemplatePackage/3.0/images/masthead_subpage.svg" alt="Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People" class="hidden-one" />
	<img src="../../TemplatePackage/3.0/images/masthead_1-col.svg" alt="Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People" class="visible-one" />
</a>

<!-- IOS9 iPad bug work around - make sure screen readers have a readable version of the logo to read
<a class="tp-sr-only" href="https://www.cdc.gov">Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People</a>
 -->
                    	</div>
                    	<!-- search -->
                    	<div id="searchArea" class="span10 hidden-one hidden-two">							
							
<div class="hidden"><a href="chlamydia.htm#" name="searchTarget">Start of Search Controls</a></div>
<form class="searchForm" method="get" action="https://search.cdc.gov/search">
	<fieldset class="search-form-wrapper ">
		<legend>Search Form Controls</legend>
		<div class="search-form-checkbox">
			<label class="subset"><input type="checkbox" name="subset" checked="checked" value="">Search The CDC</label>
		</div>
		<div class="search-input-wrapper">
			<div class="search-buttons">
				<button class="btn-clear"><span class="sprite-14-close">Cancel</span></button>
				<button class="btn-submit"><span class="sprite-14-search-black">Submit</span></button>
				<input type="submit" value="Submit" style="display:none; visibility:hidden;" /> 
			</div>
			<div class="search-input">
				<label><input type="text" placeholder="SEARCH" name="query" /><span class="hidden">Search The CDC</span></label>
			</div>
		</div>
		<input type="hidden" name="utf8" value="&#x2713;" />
					<input type="hidden" name="affiliate" value="cdc-main" />
			</fieldset>
</form>							<div class="a2z-button pull-right hidden-one hidden-two"><a href="chlamydia.htm#" id="azTab">CDC A-Z Index <span class="icon-angle-down"></span></a></div>
                    	</div>
                    </div>
                    	<div class="hidden-three hidden-four" id="mobile-menu">
		<ul>
			<li id="vp1-menu-button" class="border-bottom-white"><a href="chlamydia.htm#" id="menu-nav"><span class="sprite-16-menu"></span>MENU</a></li>
			<li id="vp1-a2z-button" class="border-bottom-white"><a href="chlamydia.htm#" id="menu-az">CDC A-Z</a></li>
			<li id="vp1-search-button" class="border-bottom-white"><a href="chlamydia.htm#" id="menu-search"><span class="sprite-16-search-white"></span>SEARCH</a></li>
		</ul>
	</div>
<script>if (typeof page_timing !== 'undefined') { page_timing.menu_load = Date.now(); }</script>
                    <div class="a2z-bar hide">
                    	<div>
	<ul>
		<li><a href="../../az/a.html">A</a></li>
		<li><a href="../../az/b.html">B</a></li>
		<li><a href="../../az/c.html">C</a></li>
		<li><a href="../../az/d.html">D</a></li>
		<li><a href="../../az/e.html">E</a></li>
		<li><a href="../../az/f.html">F</a></li>
		<li><a href="../../az/g.html">G</a></li>
		<li><a href="../../az/h.html">H</a></li>
		<li><a href="../../az/i.html">I</a></li>
		<li><a href="../../az/j.html">J</a></li>
		<li><a href="../../az/k.html">K</a></li>
		<li><a href="../../az/l.html">L</a></li>
		<li><a href="../../az/m.html">M</a></li>
		<li><a href="../../az/n.html">N</a></li>
		<li><a href="../../az/o.html">O</a></li>
		<li><a href="../../az/p.html">P</a></li>
		<li><a href="../../az/q.html">Q</a></li>
		<li><a href="../../az/r.html">R</a></li>
		<li><a href="../../az/s.html">S</a></li>
		<li><a href="../../az/t.html">T</a></li>
		<li><a href="../../az/u.html">U</a></li>
		<li><a href="../../az/v.html">V</a></li>
		<li><a href="../../az/w.html">W</a></li>
		<li><a href="../../az/x.html">X</a></li>
		<li><a href="../../az/y.html">Y</a></li>
		<li><a href="../../az/z.html">Z</a></li>
		<li><a href="../../az/0.html">#</a></li>
	</ul>
</div>
<script>if (typeof page_timing !== 'undefined') { page_timing.a2z_load = Date.now(); }</script>                    </div>
                    <div id="searchArea-two-column" class="span24 searchbar hide hidden-three hidden-four">
						  
<div class="hidden"><a href="chlamydia.htm#" name="searchTarget">Start of Search Controls</a></div>
<form class="searchForm" method="get" action="https://search.cdc.gov/search">
	<fieldset class="search-form-wrapper ">
		<legend>Search Form Controls</legend>
		<div class="search-form-checkbox">
			<label class="subset"><input type="checkbox" name="subset" checked="checked" value="">Search The CDC</label>
		</div>
		<div class="search-input-wrapper">
			<div class="search-buttons">
				<button class="btn-clear"><span class="sprite-14-close">Cancel</span></button>
				<button class="btn-submit"><span class="sprite-14-search-black">Submit</span></button>
				<input type="submit" value="Submit" style="display:none; visibility:hidden;" /> 
			</div>
			<div class="search-input">
				<label><input type="text" placeholder="SEARCH" name="query" /><span class="hidden">Search The CDC</span></label>
			</div>
		</div>
		<input type="hidden" name="utf8" value="&#x2713;" />
					<input type="hidden" name="affiliate" value="cdc-main" />
			</fieldset>
</form>					</div>
                    <!--
	See the noscript include for modifying the emergency message. DO NOT add it here.
-->
<script>if (typeof page_timing !== 'undefined') { page_timing.emergency_load = Date.now(); }</script>
    				<div class="titlebar">
    					<h2>


<a href="default.htm">2015 Sexually Transmitted Diseases Treatment Guidelines</a>

</h2>
    				</div>
    				<!-- emergency -->
<div id="emergencyContainer">
	<!--
	<div class="alert alert-error en">
		<b>Attention!</b> Uncomment this section and place the emergency message here.
	</div>
	<div class="alert alert-error esp">
		<b>&#161;Atenci&#243;n!</b> Elimine el comentario de esta secci&#243;n y colocar el mensaje de emergencia aqu&#237;.
	</div>	
	-->
</div>

<!-- no script -->
<noscript>
	<div class="alert alert-block"> Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: <a href="../../other/about_cdcgov.html">About CDC.gov</a>.</div>
</noscript>
<script>if (typeof page_timing !== 'undefined') { page_timing.noscript_load = Date.now(); }</script>
     			</div>
    		</header>
    		<div class="container">				
                <div id="content">
					<div class="row">
        				<!-- left nav -->
        				<div id="nav-container" class="hidden-one hidden-two span5">
    						<nav id="left" class="hidden-one hidden-two">
    							



<h3><a href="default.htm">2015 STD Treatment Guidelines</a></h3>

<ul id="nav-primary">
<li><a href="https://www.cdc.gov/std/tg2015/toc.htm">Table of Contents</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/intro.htm">Introduction and Methods</a></li>

<li><a href="clinical.htm">Clinical Prevention Guidance</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/specialpops.htm">Special Populations</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/emerging.htm">Emerging Issues</a></li>

<li><a href="hiv.htm">HIV Infection: Detection,Counseling and Referral</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/genital-ulcers.htm">Diseases Characterized by Genital, Anal, or Perianal Ulcers</a>
<ul>
<li><a href="https://www.cdc.gov/std/tg2015/chancroid.htm">Chancroid</a></li>

<li><a href="herpes.htm">Genital HSV Infections</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/donovanosis.htm">Granuloma Inguinale (Donovanosis)</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/lgv.htm">Lymphogranuloma Venereum (LGV)</a></li>
</ul>
</li>

<li><a href="https://www.cdc.gov/std/tg2015/syphilis.htm">Syphilis</a>
<ul>
<li><a href="https://www.cdc.gov/std/tg2015/syphilis-pregnancy.htm">Syphilis During Pregnancy</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/congenital.htm">Congenital Syphilis</a></li>
</ul>
</li>

<li><a href="https://www.cdc.gov/std/tg2015/pen-allergy.htm">Management of Persons Who Have a History of Penicillin Allergy</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/urethritis-and-cervicitis.htm">Diseases Characterized by Urethritis and Cervicitis</a></li>

<li><a href="chlamydia.htm">Chlamydial Infections</a></li>

<li><a href="gonorrhea.htm">Gonococcal Infections</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/vaginal-discharge.htm">Diseases Characterized by Vaginal Discharge</a>
<ul id="nav-primary">
<li><a href="bv.htm">Bacterial Vaginosis</a></li>

<li><a href="trichomoniasis.htm">Trichomoniasis</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/candidiasis.htm">Vulvovaginal Candidiasis</a></li>
</ul>
</li>

<li><a href="https://www.cdc.gov/std/tg2015/pid.htm">Pelvic Inflammatory Disease (PID)</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/epididymitis.htm">Epididymitis</a></li>

<li><a href="hpv.htm">Human Papillomavirus (HPV) Infection</a></li>

<li><a href="warts.htm">Anogenital Warts</a></li>

<li><a href="hpv-cancer.htm">HPV-Associated Cancers and Precancers</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/hepatitis.htm">Viral Hepatitis</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/proctitis.htm">Proctitis, Proctocolitis, and Enteritis</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/ectoparasitic.htm">Ectoparasitic Infections</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/sexual-assault.htm">Sexual Assault and Abuse and STDs</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/references.htm">References</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/terms.htm">Terms and Abbreviations Used in This Report</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/consultants.htm">Consultants</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/evidence.htm">Evidence Tables</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/screening-recommendations.htm">Screening Recommendations Referenced in Treatment Guidelines and Original Recommendation Sources</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/qa/default.htm">Questions and Answers</a>
<ul id="nav-primary">
<li><a href="https://www.cdc.gov/std/tg2015/qa/bv-qa.htm">Bacterial Vaginosis (BV)</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/qa/chlamydia-qa.htm">Chlamydia</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/qa/gonorrhea-qa.htm">Gonorrhea</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/qa/herpes-qa.htm">Herpes</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/qa/hpv-qa.htm">HPV</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/qa/mycoplasma-genitaliumqa.htm"><em>Mycoplasma genitalium</em></a></li>

<li><a href="https://www.cdc.gov/std/tg2015/qa/screening-qa.htm">Screening</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/qa/sexual-assault-qa.htm">Sexual Assault</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/qa/syphilis-qa.htm">Syphilis</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/qa/trichomoniasis-qa.htm">Trichomoniasis</a></li>
</ul>
</li>
</ul>


    						</nav>
    						<div class="nav-related">
							



    						



<div class="module-typeH">
<h3><a href="../default.htm">STDs Home Page</a></h3>

<ul class="list-block">
<li><a href="../treatment/default.htm">Treatment</a></li>
</ul>
</div>

<div class="module-typeH">
<h3>Follow STD</h3>

<ul class="list-block">
<li><a href="https://twitter.com/CDCSTD"><span class="sprite-32-twitter"><!-- marker --></span>STD on Twitter</a></li>

<li style=" text-align: left;"><a href="https://www.facebook.com/CDCSTD"><span class="sprite-32-facebook"><!-- marker --></span>STD on Facebook</a></li>
</ul>
</div>


							



							</div>    						    				
        				</div>
        				<div id="featureArea">
    						<div class="span19">
    							



    						</div>
        				</div>						
    					<div class="breadcrumbs hidden-one span19">
    						


<div class="bread-crumb hidden-one"><div class="prefix"><span><a href="../treatment/default.htm">Treatment</a></span> <span><a href="../default.htm">Sexually Transmitted Diseases</a></span></div></div>

    					</div>
						<div class="span19 pagetitle">	
    						    						    							<div class='mSyndicate'>
    																					<h1>Chlamydial Infections</h1>
															    						    						    							</div>
    												</div>
						<div id="share-bar" class="span19">		
    						<div class="socialmediabar">
								<div class="row">
            						<div class="hidden-one pull-right">
        								            							            							            						</div>	
    								<div class="span8">
    									<div id="socialMediaShareContainer">
	<div class="share_container noLinking">
	 	<a class="share_button_facebook" title="Facebook" href="chlamydia.htm#"><span class="tp-sr-only">Recommend on Facebook</span><span id="share_facebook" class="facebookRecommend"> </span></a>
	 	<a class="share_button_twitter" title="Twitter" href="chlamydia.htm#"><span class="tp-sr-only">Tweet</span><span id="share_twitter" class="twitterTweet"> </span></a>
		<a class="share_button" href="chlamydia.htm#socialMediaShareContainer" ><img src="../../TemplatePackage/3.0/images/social/addthis-32.png" alt="Share" /><span class="shareButtonEn tp-sr-only" aria-label="Share">Share</span><span class="shareButtonEs tp-sr-only" aria-label="Compartir">Compartir</span></a>
	</div>
</div>

<!-- target anchor for return to top feature in VP1 -->
<a id="content-start" tabindex="-1"></a>
    								</div>
								</div>
    						</div>
    					</div>	
    					<!-- body -->
    					<div id="body" class="span19">
    						<div id="contentArea" >								
        						        														
			<div class="span6 pull-right">
    		<div id="onthispage2" class="module-typeF">
				    			<h4>On this Page</h4>				    			<ul class="list-bullet">
    				    				<li><a href="chlamydia.htm#adults">Chlamydial Infections in Adolescents and Adults</a></li>    				    				<li><a href="chlamydia.htm#neonates">Chlamydial Infections Among Neonates</a></li>    				    				<li><a href="chlamydia.htm#children">Chlamydial Infections Among Infants and Children</a></li>    				    			</ul>
    		</div>
		</div>
	  								        						                                                                                            					            					            						<div class='mSyndicate'>
            					            					        							<h3><a class="onThisPageAnchor" id="adults" name="adults" title="Chlamydial Infections in Adolescents and Adults"></a>Chlamydial Infections in Adolescents and Adults</h3><p>Chlamydial infection is the most frequently reported infectious disease in the United States, and prevalence is highest in persons aged &#8804;24 years (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#118">118</a></em>). Several sequelae can result from <em>C. trachomatis</em> infection in women, the most serious of which include PID, ectopic pregnancy, and infertility. Some women who receive a diagnosis of uncomplicated cervical infection already have subclinical upper-reproductive&#8211;tract infection.</p><p>Asymptomatic infection is common among both men and women. To detect chlamydial infections, health-care providers frequently rely on screening tests. Annual screening of all sexually active women aged &lt;25 years is recommended, as is screening of older women at increased risk for infection (e.g., those who have a new sex partner, more than one sex partner, a sex partner with concurrent partners, or a sex partner who has a sexually transmitted infection (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#108">108</a></em>). Although CT incidence might be higher in some women aged &#8805;25 years in some communities, overall the largest burden of infection is among women aged &lt;25 years.</p><p>Chlamydia screening programs have been demonstrated to reduce the rates of PID in women (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#497">497,498</a></em>). Although evidence is insufficient to recommend routine screening for <em>C. trachomatis</em> in sexually active young men because of several factors (e.g., feasibility, efficacy, and cost-effectiveness), the screening of sexually active young men should be considered in clinical settings with a high prevalence of chlamydia (e.g., adolescent clinics, correctional facilities, and STD clinics) or in populations with high burden of infection (e.g., MSM) <em>(<a href="https://www.cdc.gov/std/tg2015/references.htm#108">108</a>,<a href="https://www.cdc.gov/std/tg2015/references.htm#121">121</a>)</em>. Among women, the primary focus of chlamydia screening efforts should be to detect chlamydia, prevent complications, and test and treat their partners, whereas targeted chlamydia screening in men should only be considered when resources permit, prevalence is high, and such screening does not hinder chlamydia screening efforts in women (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#499">499,500</a></em>). More frequent screening for some women (e.g., adolescents) or certain men (e.g., MSM) might be indicated.</p><h4><a id="diag"></a>Diagnostic Considerations</h4><p><em>C. trachomatis</em> urogenital infection can be diagnosed in women by testing first-catch urine or collecting swab specimens from the endocervix or vagina. Diagnosis of <em>C. trachomatis</em> urethral infection in men can be made by testing a urethral swab or first-catch urine specimen. NAATs are the most sensitive tests for these specimens and therefore are recommended for detecting <em>C. trachomatis</em> infection (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#394">394</a></em>). NAATs that are FDA-cleared for use with vaginal swab specimens can be collected by a provider or self-collected in a clinical setting. Self-collected vaginal swab specimens are equivalent in sensitivity and specificity to those collected by a clinician using NAATs (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#501">501,502</a></em>), and women find this screening strategy highly acceptable (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#503">503,504</a></em>). Optimal urogenital specimen types for chlamydia screening using NAAT include first catch-urine (men) and vaginal swabs (women) (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#394">394</a></em>). Rectal and oropharyngeal <em>C. trachomatis</em> infection in persons engaging in receptive anal or oral intercourse can be diagnosed by testing at the anatomic site of exposure. NAATs are not FDA-cleared for use with rectal or oropharyngeal swab specimens. However, NAATs have been demonstrated to have improved sensitivity and specificity compared with culture for the detection of <em>C. trachomatis</em> at rectal sites (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#505">505-507</a></em>) and at oropharyngeal sites among men (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#505">505-508</a></em>). Some laboratories have established CLIA-defined performance specifications when evaluating rectal and oropharyngeal swab specimens for <em>C. trachomatis,</em> thereby allowing results to be used for clinical management. Most persons with <em>C. trachomatis</em> detected at oropharyngeal sites do not have oropharyngeal symptoms. However, when gonorrhea testing is performed at the oropharyngeal site, chlamydia test results might be reported as well because some NAATs detect both bacteria from a single specimen. Data indicate that performance of NAATs on self-collected rectal swabs is comparable to clinician-collected rectal swabs, and this specimen collection strategy for rectal <em>C. trachomatis</em> screening is highly acceptable (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#509">509-511</a></em>). Self-collected rectal swabs are a reasonable alternative to clinician-collected rectal swabs for <em>C. trachomatis</em> screening by NAAT, especially when clinicians are not available or when self collection is preferred over clinician collection. Previous evidence suggests that the liquid-based cytology specimens collected for Pap smears might be acceptable specimens for NAAT testing, although test sensitivity using these specimens might be lower than that associated with use of cervical or vaginal swab specimens (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#512">512</a></em>); regardless, certain NAATs have been FDA-cleared for use on liquid-based cytology specimens.</p><h4><a id="treatment"></a>Treatment</h4><p>Treating persons infected with <em>C. trachomatis</em> prevents adverse reproductive health complications and continued sexual transmission, and treating their sex partners can prevent reinfection and infection of other partners. Treating pregnant women usually prevents transmission of <em>C. trachomatis</em> to neonates during birth. Chlamydia treatment should be provided promptly for all persons testing positive for infection; treatment delays have been associated with complications (e.g., PID) in a limited proportion of women (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#513">513</a></em>).</p><div class="module-typeF"><h5><em>Recommended Regimens</em></h5><ul class="list-block"><li><strong>Azithromycin</strong> 1 g orally in a single dose<br />OR</li><li><strong>Doxycycline</strong> 100 mg orally twice a day for 7 days</li></ul><h5><em>Alternative Regimens</em></h5><ul class="list-block"><li><strong>Erythromycin</strong> base 500 mg orally four times a day for 7 days<br />OR</li><li><strong>Erythromycin</strong> ethylsuccinate 800 mg orally four times a day for 7 days<br />OR</li><li><strong>Levofloxacin</strong> 500 mg orally once daily for 7 days<br />OR</li><li><strong>Ofloxacin</strong> 300 mg orally twice a day for 7 days</li></ul></div><p>A meta-analysis of 12 randomized clinical trials of azithromycin versus doxycycline for the treatment of urogenital chlamydial infection demonstrated that the treatments were equally efficacious, with microbial cure rates of 97% and 98%, respectively (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#514">514</a></em>). These studies were conducted primarily in populations with urethral and cervical infection in which follow-up was encouraged, adherence to a 7-day regimen was effective, and culture or EIA (rather than the more sensitive NAAT) was used for determining microbiological outcome. More recent retrospective studies have raised concern about the efficacy of azithromycin for rectal <em>C. trachomatis</em> infection (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#515">515,516</a></em><a href="https://www.cdc.gov/std/tg2015/references.htm#515">)</a>, however, these studies have limitations, and prospective clinical trials comparing azithromycin versus doxycycline regimens for rectal <em>C. trachomatis</em> infection are needed.</p><p>Although the clinical significance of oropharyngeal <em>C. trachomatis</em> infection is unclear and routine oropharyngeal screening for CT is not recommended, available evidence suggests oropharyngeal <em>C. trachomatis</em> can be sexually transmitted to genital sites (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#152">152</a>,<a href="https://www.cdc.gov/std/tg2015/references.htm#517">517</a></em>); therefore, detection of <em>C. trachomatis</em> from an oropharyngeal specimen should be treated with azithromycin or doxycycline. The efficacy of alternative antimicrobial regimens in resolving oropharyngeal chlamydia remains unknown.</p><p>In a double-blinded randomized control trial, a doxycycline delayed-release 200 mg tablet administered daily for 7 days was as effective as generic doxycycline 100 mg twice daily for 7 days for treatment of urogenital <em>C. trachomatis</em> infection in men and women and had a lower frequency of gastrointestinal side effects. However, this regimen is more costly than those that involve multiple daily doses (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#518">518</a></em>). Delayed-release doxycycline (Doryx) 200 mg daily for 7 days might be an alternative regimen to the doxycycline 100 mg twice daily for 7 days for treatment of urogenital <em>C. trachomatis</em> infection. Erythromycin might be less efficacious than either azithromycin or doxycycline, mainly because of the frequent occurrence of gastrointestinal side effects that can lead to nonadherence with treatment. Levofloxacin and ofloxacin are effective treatment alternatives, but they are more expensive and offer no advantage in the dosage regimen. Other quinolones either are not reliably effective against chlamydial infection or have not been evaluated adequately.</p><h4>Other Management Considerations</h4><p>To maximize adherence with recommended therapies, onsite, directly observed single-dose therapy with azithromycin should always be available for persons for whom adherence with multiday dosing is a concern. In addition, for multidose regimens, the first dose should be dispensed on site and directly observed. To minimize disease transmission to sex partners, persons treated for chlamydia should be instructed to abstain from sexual intercourse for 7 days after single-dose therapy or until completion of a 7-day regimen and resolution of symptoms if present. To minimize risk for reinfection, patients also should be instructed to abstain from sexual intercourse until all of their sex partners are treated. Persons who receive a diagnosis of chlamydia should be tested for HIV, GC, and syphilis.</p><h4><a id="Follow-Up"></a>Follow-Up</h4><p>Test-of-cure to detect therapeutic failure (i.e., repeat testing 3&#8211;4 weeks after completing therapy) is not advised for persons treated with the recommended or alterative regimens, unless therapeutic adherence is in question, symptoms persist, or reinfection is suspected. Moreover, the use of chlamydial NAATs at &lt;3 weeks after completion of therapy is not recommended because the continued presence of nonviable organisms (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#394">394,395</a>,<a href="https://www.cdc.gov/std/tg2015/references.htm#519">519</a></em>) can lead to false-positive results.</p><p>A high prevalence of <em>C. trachomatis</em> infection has been observed in women and men who were treated for chlamydial infection during the preceding several months (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#480">480,481</a>,<a href="https://www.cdc.gov/std/tg2015/references.htm#520">520-522</a></em>). Most post-treatment infections do not result from treatment failure, but rather from reinfection caused by failure of sex partners to receive treatment or the initiation of sexual activity with a new infected partner, indicating a need for improved education and treatment of sex partners. Repeat infections confer an elevated risk for PID and other complications in women. Men and women who have been treated for chlamydia should be retested approximately 3 months after treatment, regardless of whether they believe that their sex partners were treated (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#480">480,481</a></em>). If retesting at 3 months is not possible, clinicians should retest whenever persons next present for medical care in the 12-month period following initial treatment.</p><h4>Management of Sex Partners</h4><p>Sex partners should be referred for evaluation, testing, and presumptive treatment if they had sexual contact with the partner during the 60 days preceding the patient&#8217;s onset of symptoms or chlamydia diagnosis. Although the exposure intervals defined for the identification of at-risk sex partners are based on limited data, the most recent sex partner should be evaluated and treated, even if the time of the last sexual contact was &gt;60 days before symptom onset or diagnosis.</p><p>Among heterosexual patients, if health department partner management strategies (e.g., disease intervention specialists) are impractical or not available for persons with chlamydia and a provider is concerned that sex partners are unable to promptly access evaluation and treatment services, EPT should be considered as permitted by law (see <a href="clinical.htm#partner">Partner Services</a>). Compared with standard patient referral of partners, this approach to therapy, which involves delivering the medication itself or a prescription, has been associated with decreased rates of persistent or recurrent chlamydia (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#93">93-95</a></em>). Providers should also provide patients with written educational materials to give to their partner(s) about chlamydia in general, to include notification that partner(s) have been exposed and information about the importance of treatment. These materials also should inform partners about potential therapy-related allergies and adverse effects, along with symptoms suggestive of complications (e.g., testicular pain in men and pelvic or abdominal pain in women). EPT is not routinely recommended for MSM with chlamydia because of a high risk for coexisting infections (especially undiagnosed HIV) among their partners, and because data are limited regarding the effectiveness of this approach in reducing persistent or recurrent chlamydia among MSM. Having partners accompany patients when they return for treatment is another strategy that has been used to ensure partner treatment (See <a href="clinical.htm#partner">Partner Services</a>). To avoid reinfection, sex partners should be instructed to abstain from sexual intercourse until they and their sex partners have been adequately treated (i.e., for 7 days after a single-dose regimen or after completion of a 7-day regimen) and have resolved any symptoms.</p><h4><a id="spec-con"></a>Special Considerations</h4><h5>Pregnancy</h5><p>Doxycycline is contraindicated in the second and third trimesters of pregnancy. Human data suggest ofloxacin and levofloxacin present a low risk to the fetus during pregnancy, with a potential for toxicity during breastfeeding; however, data from animal studies raise concerns about cartilage damage to neonates (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#317">317</a></em>). Thus, alternative drugs should be used to treat chlamydia in pregnancy. Clinical experience and published studies suggest that azithromycin is safe and effective (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#523">523-525</a></em>). Test-of-cure to document chlamydial eradication (preferably by NAAT) 3&#8211;4 weeks after completion of therapy is recommended because severe sequelae can occur in mothers and neonates if the infection persists. In addition, all pregnant women who have chlamydial infection diagnosed should be retested 3 months after treatment. Detection of <em>C. trachomatis</em> infection at repeat screening during the third semester is not uncommon in adolescent and young adult women, including in those without <em>C. trachomatis</em> detected at the time of initial prenatal screening (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#526">526,527</a></em>). Women aged &lt;25 years and those at increased risk for chlamydia (e.g., those who have a new sex partner, more than one sex partner, a sex partner with concurrent partners, or a sex partner who has a sexually transmitted infection) should be rescreened during the third trimester to prevent maternal postnatal complications and chlamydial infection in the infant (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#108">108</a></em>).</p><div class="module-typeF"><h5><em>Recommended Regimens</em></h5><ul class="list-block"><li><strong>Azithromycin</strong> 1 g orally in a single dose</li></ul><h5><em>Alternative Regimens</em></h5><ul class="list-block"><li><strong>Amoxicillin</strong> 500 mg orally three times a day for 7 days<br />OR</li><li><strong>Erythromycin</strong> base 500 mg orally four times a day for 7 days<br />OR</li><li><strong>Erythromycin</strong> base 250 mg orally four times a day for 14 days<br />OR</li><li><strong>Erythromycin</strong> ethylsuccinate 800 mg orally four times a day for 7 days<br />OR</li><li><strong>Erythromycin</strong> ethylsuccinate 400 mg orally four times a day for 14 days</li></ul></div><p>Because of concerns about chlamydia persistence following exposure to penicillin-class antibiotics that has been demonstrated in animal and in vitro studies, amoxicillin is now considered an alternative therapy for <em>C. trachomatis</em> in pregnant women (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#528">528,529</a></em>). The frequent gastrointestinal side effects associated with erythromycin can result in nonadherence with these alternative regimens. The lower dose 14-day erythromycin regimens can be considered if gastrointestinal tolerance is a concern. Erythromycin estolate is contraindicated during pregnancy because of drug-related hepatotoxicity.</p><h5>HIV Infection</h5><p>Persons who have chlamydia and HIV infection should receive the same treatment regimen as those who do not have HIV infection. For more information, see <a href="chlamydia.htm#treatment">Chlamydia, Treatment</a>.</p><p style=" text-align: right;"><span class="toTop"><span class="icon-angle-up"><!-- --></span>&#160;<a href="chlamydia.htm#">Top of Page</a></span></p><h3><a class="onThisPageAnchor" id="neonates" name="neonates" title="Chlamydial Infections Among Neonates"></a>Chlamydial Infections Among Neonates</h3><p>Prenatal screening and treatment of pregnant women is the best method for preventing chlamydial infection among neonates. <em>C. trachomatis</em> infection of neonates results from perinatal exposure to the mother&#8217;s infected cervix. Although the efficacy of neonatal ocular prophylaxis with erythromycin ophthalmic ointments to prevent chlamydia ophthalmia is not clear, ocular prophylaxis with these agents prevents gonococcal ophthalmia and therefore should be administered (see <a href="gonorrhea.htm#op-neo">Ophthalmia Neonatorum Caused by</a> <em><a href="gonorrhea.htm#op-neo">N. gonnorrhoeae</a>).</em></p><p>Initial <em>C. trachomatis</em> neonatal infection involves the mucous membranes of the eye, oropharynx, urogenital tract, and rectum, although infection might be asymptomatic in these locations. Instead, <em>C. trachomatis</em> infection in neonates is most frequently recognized by conjunctivitis that develops 5&#8211;12 days after birth. <em>C. trachomatis</em> also can cause a subacute, afebrile pneumonia with onset at ages 1&#8211;3 months. Although <em>C. trachomatis</em> has been the most frequent identifiable infectious cause of ophthalmia neonatorum, neonatal chlamydial infections (including ophthalmia and pneumonia) have occurred less frequently since the institution of widespread prenatal screening and treatment of pregnant women.</p><h4><a id="op-neo"></a>Ophthalmia Neonatorum Caused by <em>C. trachomatis</em></h4><p>A chlamydial etiology should be considered for all infants aged &#8804;30 days that have conjunctivitis, especially if the mother has a history of chlamydia infection. These infants should receive evaluation and appropriate care and treatment.</p><h5>Diagnostic Considerations</h5><p>Sensitive and specific methods used to diagnose chlamydial ophthalmia in the neonate include both tissue culture and nonculture tests (e.g., direct fluorescence antibody [DFA] tests and NAAT). DFA is the only nonculture FDA-cleared test for the detection of chlamydia from conjunctival swabs; NAATs are not FDA-cleared for the detection of chlamydia from conjunctival swabs, and clinical laboratories must verify the procedure according to CLIA regulations. Specimens for culture isolation and nonculture tests should be obtained from the everted eyelid using a dacron-tipped swab or the swab specified by the manufacturer&#8217;s test kit; for culture and DFA, specimens must contain conjunctival cells, not exudate alone. Ocular specimens from neonates being evaluated for chlamydial conjunctivitis also should be tested for <em>N. gonorrhoeae</em> (see <a href="gonorrhea.htm#op-neo">Ophthalmia Neonatorum Caused by</a> <em><a href="gonorrhea.htm#op-neo">N. gonnorrhoeae</a></em>).</p><h5><em>Treatment of Ophthalmia Neonatorum</em></h5><div class="module-typeF"><h5><em>Recommended Regimen</em></h5><ul class="list-block"><li><strong>Erythromycin</strong> base or ethylsuccinate 50 mg/kg/day orally divided into 4 doses daily for 14 days*</li></ul><h5><em>Alternative Regimen</em></h5><ul class="list-block"><li><strong>Azithromycin</strong> suspension, 20 mg/kg/day orally, 1 dose daily for 3 days*</li></ul><p>*An association between oral erythromycin and azithromycin and infantile hypertrophic pyloric stenosis (IHPS) has been reported in infants aged &lt;6 weeks. Infants treated with either of these antimicrobials should be followed for signs and symptoms of IHPS.</p></div><p>Although data on the use of azithromycin for the treatment of neonatal chlamydia infection are limited, available data suggest a short course of therapy might be effective (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#530">530</a></em>). Topical antibiotic therapy alone is inadequate for treatment for ophthalmia neonatorum caused by chlamydia and is unnecessary when systemic treatment is administered.</p><h5>Follow-Up</h5><p>Because the efficacy of erythromycin treatment for ophthalmia neonatorum is approximately 80%, a second course of therapy might be required (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#531">531</a></em>). Data on the efficacy of azithromycin for ophthalmia neonatorum are limited. Therefore, follow-up of infants is recommended to determine whether initial treatment was effective. The possibility of concomitant chlamydial pneumonia should be considered (see <a href="chlamydia.htm#Pneumonia">Infant Pneumonia Caused by</a> <em><a href="chlamydia.htm#Pneumonia">C. trachomatis</a></em>).</p><h5>Management of Mothers and Their Sex Partners</h5><p>Mothers of infants who have ophthalmia caused by chlamydia and the sex partners of these women should be evaluated and presumptively treated for chlamydia. For more information, see <a href="chlamydia.htm#adults">Chlamydial Infection in Adolescents and Adults</a>.</p><h4><a id="Pneumonia"></a>Infant Pneumonia Caused by <em>C. trachomatis</em></h4><p>Chlamydia pneumonia in infants typically occurs at 1&#8211;3 months and is a subacute pneumonia. Characteristic signs of chlamydial pneumonia in infants include 1) a repetitive staccato cough with tachypnea and 2) hyperinflation and bilateral diffuse infiltrates on a chest radiograph. In addition, peripheral eosinophilia (&#8805;400 cells/mm3) occurs frequently. Because clinical presentations differ, all infants aged 1&#8211;3 months suspected of having pneumonia (especially those whose mothers have a history of chlamydial infection) should be tested for <em>C. trachomatis</em> and treated if infected.</p><h5>Diagnostic Considerations</h5><p>Specimens for chlamydial testing should be collected from the nasopharynx. Tissue culture is the definitive standard diagnostic test for chlamydial pneumonia. Nonculture tests (e.g., DFA and NAAT) can be used. DFA is the only nonculture FDA-cleared test for the detection of <em>C. trachomatis</em> from nasopharyngeal specimens, but DFA of nasopharyngeal specimens has a lower sensitivity and specificity than culture. NAATs are not FDA-cleared for the detection of chlamydia from nasopharyngeal specimens, and clinical laboratories must verify the procedure according to CLIA regulations (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#394">394</a></em>). Tracheal aspirates and lung biopsy specimens, if collected, should be tested for <em>C. trachomatis</em>.</p><h5>Treatment</h5><p>Because test results for chlamydia often are not available at the time that initial treatment decisions must be made, treatment for <em>C. trachomatis</em> pneumonia must frequently be based on clinical and radiologic findings, age of the infant (i.e., 1&#8211;3 months), and risk of chlamydia in the mother (i.e., age &lt;25, multiple partners, and history of chlamydial infection). The results of tests for chlamydial infection assist in the management of an infant&#8217;s illness.</p><div class="module-typeF"><h5><em>Recommended Regimen</em></h5><ul class="list-block"><li><strong>Erythromycin</strong> base or ethylsuccinate 50 mg/kg/day orally divided into 4 doses daily for 14 days</li></ul><h5><em>Alternative Regimen</em></h5><ul class="list-block"><li><strong>Azithromycin</strong> 20 mg/kg/day orally, 1 dose daily for 3 days</li></ul></div><h5>Follow-Up</h5><p>Because the effectiveness of erythromycin in treating pneumonia caused by <em>C. trachomatis</em> is approximately 80%, a second course of therapy might be required (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#532">532</a></em>). Data on the effectiveness of azithromycin in treating chlamydial pneumonia are limited. Follow-up of infants is recommended to determine whether the pneumonia has resolved, although some infants with chlamydial pneumonia continue to have abnormal pulmonary function tests later in childhood.</p><h5>Management of Mothers and Their Sex Partners</h5><p>Mothers of infants who have chlamydia pneumonia and the sex partners of these women should be evaluated, tested, and presumptively treated for chlamydia. For more information, see <a href="chlamydia.htm#adults">Chlamydial Infection in Adolescents and Adults</a>.</p><h4>Neonates Born to Mothers Who Have Chlamydial Infection</h4><p>Neonates born to mothers who have untreated chlamydia are at high risk for infection; however, prophylactic antibiotic treatment is not indicated, as the efficacy of such treatment is unknown. Infants should be monitored to ensure appropriate treatment if symptoms develop.</p><p style=" text-align: right;"><span class="toTop"><span class="icon-angle-up"><!-- --></span>&#160;<a href="chlamydia.htm#">Top of Page</a></span></p><h3><a class="onThisPageAnchor" id="children" name="children" title="Chlamydial Infections Among Infants and Children"></a>Chlamydial Infections Among Infants and Children</h3><p>Sexual abuse must be considered a cause of chlamydial infection in infants and children. However, perinatally transmitted <em>C. trachomatis</em> infection of the nasopharynx, urogenital tract, and rectum might persist for 2&#8211;3 years (see <a href="https://www.cdc.gov/std/tg2015/sexual-assault.htm#children">Sexual Assault or Abuse of Children</a>).</p><h4>Diagnostic Considerations</h4><p>NAAT can be used for vaginal and urine specimens from girls (see Sexual Assault or Abuse of Children), although data are insufficient to recommend the use of NAAT in boys. Data also are lacking regarding use of NAAT for specimens from extragenital sites (rectum and pharynx) in boys and girls (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#394">394</a></em>); other nonculture tests (e.g., DFA) are not recommended because of specificity concerns. Culture is still the preferred method for detection of urogenital <em>C. trachomatis</em> in boys and at extragenital sites in boys and girls.</p><div class="module-typeF"><h5><em>Recommended Regimen for Infants and Children Who Weigh &lt;45 kg</em></h5><ul class="list-block"><li><strong>Erythromycin</strong> base or ethylsuccinate 50 mg/kg/day orally divided into 4 doses daily for 14 days</li></ul><p>Data are limited on the effectiveness and optimal dose of azithromycin for the treatment of chlamydial infection in infants and children who weigh &lt;45 kg</p><h5><em>Recommended Regimen for Children Who Weigh &#8805;45 kg but Who Are Aged &lt;8 Years</em></h5><ul class="list-block"><li><strong>Azithromycin</strong> 1 g orally in a single dose</li></ul><h5><em>Recommended Regimens for Children Aged &#8805;8 years</em></h5><ul class="list-block"><li><strong>Azithromycin</strong> 1 g orally in a single dose<br />OR</li><li><strong>Doxycycline</strong> 100 mg orally twice a day for 7 days</li></ul></div><h4>Other Management Considerations</h4><p>See <a href="https://www.cdc.gov/std/tg2015/sexual-assault.htm#children">Sexual Assault or Abuse of Children</a>.</p><h4>Follow-Up</h4><p>A test-of-cure culture (repeat testing after completion of therapy) to detect therapeutic failure ensures treatment effectiveness. Therefore, this culture with should be obtained at a follow-up visit approximately 2 weeks after treatment is completed.</p><p style=" text-align: right;"><span class="toTop"><span class="icon-angle-up"><!-- --></span>&#160;<a href="chlamydia.htm#">Top of Page</a></span></p><p>&#160;</p><p style=" text-align: right;"><a href="gonorrhea.htm">Next</a></p>             					            					            					            						</div>
            													        						                                                                                        						                                                                								<!-- Related Nav Area -->
								<div class="nav-related hidden-three hidden-four">
									



									



<div class="module-typeH">
<h3><a href="../default.htm">STDs Home Page</a></h3>

<ul class="list-block">
<li><a href="../treatment/default.htm">Treatment</a></li>
</ul>
</div>

<div class="module-typeH">
<h3>Follow STD</h3>

<ul class="list-block">
<li><a href="https://twitter.com/CDCSTD"><span class="sprite-32-twitter"><!-- marker --></span>STD on Twitter</a></li>

<li style=" text-align: left;"><a href="https://www.facebook.com/CDCSTD"><span class="sprite-32-facebook"><!-- marker --></span>STD on Facebook</a></li>
</ul>
</div>


								</div>
    							<!-- Persistent Content Area -->
    							<div id="content-secondary">
                                    



            						



    							</div><!-- /end #content-secondary -->
    						</div><!-- /end #contentArea -->
    					</div><!-- /end body -->	
					</div>
					<div class="row">
						<div class="span24 visible-one">
																											</div>
					</div>
					<div class="row">
						<div class="span24">
                            <div id="plugin-legend" class="pluginOff">
	<h5>File Formats Help:</h5><span><a href="../../Other/plugins/index.html">How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?</a></span>
	<ul>
		<li class="plugin-pdf"><a href="../../Other/plugins/index.html#pdf"><span class="sprite-16-pdf">Adobe PDF file</span></a></li>
		<li class="plugin-ppt"><a href="../../Other/plugins/index.html#ppt"><span class="sprite-16-ppt">Microsoft PowerPoint file</span></a></li>
		<li class="plugin-word"><a href="../../Other/plugins/index.html#doc"><span class="sprite-16-word">Microsoft Word file</span></a></li>
		<li class="plugin-excel"><a href="../../Other/plugins/index.html#xls"><span class="sprite-16-excel">Microsoft Excel file</span></a></li>
		<li class="plugin-wmv"><a href="../../Other/plugins/index.html#wmv"><span class="sprite-16-wmv">Audio/Video file</span></a></li>
		<li class="plugin-qt"><a href="../../Other/plugins/index.html#qt"><span class="sprite-16-qt">Apple Quicktime file</span></a></li>
		<li class="plugin-real"><a href="../../Other/plugins/index.html#ram"><span class="sprite-16-rp">RealPlayer file</span></a></li>
		<li class="plugin-text"><a href="../../Other/plugins/index.html#text"><span class="sprite-16-txt">Text file</span></a></li>
		<li class="plugin-zip"><a href="../../Other/plugins/index.html#zip"><span class="sprite-16-zip">Zip Archive file</span></a></li>
		<li class="plugin-sas"><a href="../../Other/plugins/index.html#sas"><span class="sprite-16-sas">SAS file</span></a></li>
		<li class="plugin-epub"><a href="../../Other/plugins/index.html#epub"><span class="sprite-16-ebook">ePub file</span></a></li>
		<li class="plugin-ris"><a href="../../Other/plugins/index.html#ris"><span class="sprite-16-ris">RIS file</span></a></li>
	</ul>
</div>
						</div>
					</div>
					<!-- date stamp -->
					<div id="datestamp" class="row" itemscope="itemscope" itemtype="http://schema.org/WebPage">
						<div class="span24">
    						<ul> 
            					            						<li class="last-reviewed">Page last reviewed: <span itemprop="lastReviewed">June 4, 2015</span></li>
            													            					            						<li class="last-updated">Page last updated: <span itemprop="dateModified">June 4, 2015</span></li>
            					        							<li class="content-source">Content source:
    									


<ul class="noindent"><li class="" itemprop="sourceOrganization" itemscope="itemscope" itemtype="http://schema.org/Organization"><a href="../dstdp.1.html" itemprop="url">Division of STD Prevention</a>, <a href="../../nchhstp.1.html" itemprop="url">National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention</a>, <a href="../../index.html" itemprop="url">Centers for Disease Control and Prevention</a></li></ul>

        							</li>
									



    						</ul>
						</div>
					</div>					
				</div><!-- /end #content -->
			</div><!-- /.container for content -->					
			<!-- footer -->
				<footer id="footer" class="cdcSlimFooter">
	
 <!-- include eng footerSubSocialMedia.html -->
<div class="socialMedia">
	<div class="container">
		<nav class="followcdc">
			<ul>
				<li><a href="../../Other/emailupdates.1.html"><span class="sprite-24-govd"></span><span class="tp-sr-only">Email</span></a></li>
				<li><a href="https://www.facebook.com/CDC" target="_blank"><span class="sprite-24-facebook"></span><span class="tp-sr-only">Recommend</span></a></li>
				<li><a href="https://twitter.com/CDCgov" target="_blank"><span class="sprite-24-twitter"></span><span class="tp-sr-only">Tweet</span></a></li>
				<li><a href="https://www.youtube.com/user/CDCstreamingHealth" target="_blank"><span class="sprite-24-youtube"></span><span class="tp-sr-only">YouTube</span></a></li>
				<li><a href="https://www.instagram.com/CDCgov/" target="_blank"><span class="sprite-24-instagram"></span><span class="tp-sr-only">Instagram</span></a></li>
			</ul>
		</nav>
		<nav class="cdcmedia">
			<ul>
				<li><a href="https://www2c.cdc.gov/podcasts"><span class="sprite-24-listen"></span><span class="tp-sr-only">Listen</span></a></li>
				<li><a href="../../cdctv.1.html"><span class="sprite-24-watch"></span><span class="tp-sr-only">Watch</span></a></li>
				<li><a href="https://www2c.cdc.gov/podcasts/rss.asp"><span class="sprite-24-rss"></span><span class="tp-sr-only">RSS</span></a></li>
			</ul>
		</nav>
	</div>
</div>
 <!-- /include eng footerSubSocialMedia.html -->

	<div class="container">
		<div class="cdcLinks">
			<div class="container">
				<ul>
					
<!-- include eng footerSubCdcLinks.html-->
<li>
	<nav>
		<h6 class="hidden-four hidden-three">ABOUT <span class="icon-plus visible-one pull-right"></span></h6>
		<ul class="hidden-one">
			<li><a href="../../about/default.htm">About CDC</a></li>
			<li><a href="https://jobs.cdc.gov">Jobs</a></li>
			<li><a href="../../funding.1.html">Funding</a></li>
		</ul>
	</nav>
</li>
<li>
	<nav>
		<h6 class="hidden-four hidden-three">LEGAL <span class="icon-plus visible-one pull-right"></span></h6>
		<ul class="hidden-one">
			<li><a href="../../Other/policies.html">Policies</a></li>
			<li><a href="../../Other/privacy.html">Privacy</a></li>
			<li><a href="../../od/foia.1.html">FOIA</a></li>
			<li><a href="../../eeo/nofearact/index.htm">No Fear Act</a></li>
			<li><a href="https://oig.hhs.gov" class="no-link">OIG</a></li>
		</ul>
	</nav>
</li>
<!--/ include eng footerSubCdcLinks.html-->

				</ul>
			</div>
		</div>
		<div class="cdcContact">
			<div class="container">
				<ul>
					<li class="local-contact">
						
 <!-- include eng footerSubGlobalContact1.html -->
<section>
	<address class="address" itemscope="itemscope" itemtype="https://schema.org/Organization">
		<span class="value" itemprop="address" itemscope="itemscope" itemtype="https://schema.org/PostalAddress">
			<span itemprop="streetAddress">1600 Clifton Road</span>
			<span itemprop="addressLocality">Atlanta</span>,
			<span itemprop="addressRegion">GA</span>
			<span itemprop="postalCode">30329-4027</span>
			<span itemprop="addressCountry">USA</span>
		</span><br />
		<span class="value" itemprop="telephone">800-CDC-INFO (800-232-4636)</span>,
		<span class="value" itemprop="telephone">TTY: 888-232-6348</span><br />
		<span class="value" itemprop="contactPoint" itemscope="itemscope" itemtype="https://schema.org/ContactPoint">
			<span itemprop="url"><a href="https://wwwn.cdc.gov/dcs/RequestForm.aspx" class=" default no-link">Email CDC-INFO</a></span>
		</span>
	</address>
</section>
 <!-- /include eng footerSubGlobalContact1.html -->

					</li>
					<li class="contact">
						
 <!-- include eng footerSubGlobalContact2.html -->
<section>
	<address class="address" itemscope="itemscope" itemtype="https://schema.org/Organization">
		<span class="value" itemprop="contactPoint" itemscope="itemscope" itemtype="https://schema.org/ContactPoint">
			<span itemprop="url"><a href="https://www.hhs.gov" class="no-link">U.S. Department of Health & Human Services</a></span>
		</span><br />
        <span class="value" itemprop="contactPoint" itemscope="itemscope" itemtype="https://schema.org/ContactPoint">
        	<span itemprop="url"><a href="https://www.hhs.gov/open" class="no-link">HHS/Open</a></span>
        </span><br />
        <span class="value" itemprop="contactPoint" itemscope="itemscope" itemtype="https://schema.org/ContactPoint">
			<span itemprop="url"><a href="https://www.usa.gov/" class="no-link">USA.gov</a></span>
		</span>
	</address>
</section>
 <!-- /include eng footerSubGlobalContact2.html -->

					</li>
				</ul>
			</div>
		</div>
	</div>
</footer>			<!-- /#footer -->
			<div id="totop" class="off visible-one">Top</div>
        </div>
		<script>page_timing.libs_start = Date.now();</script><script src="../../TemplatePackage/3.0/js/libs.min.js@3.2.1.7"></script><script>page_timing.libs_end = Date.now();page_timing.core_start = Date.now();</script><script src="../../TemplatePackage/3.0/js/core.min.js@3.2.1.7"></script><script>page_timing.core_end = Date.now();</script><!-- Start Site Settings Overrides -->
<script>
CDC.Constants.set("flexSliderVideoDomains", ['youtube.com','ytimg.com','vimeocdn.com'], 'es');
	CDC.Global.settings.includeCDCInBreadCrumbBar=false;
</script>
<!-- End Site Settings Overrides --><script>page_timing.app_start = Date.now();</script><script src="../../TemplatePackage/3.0/js/app.min.js@3.2.1.7"></script><script>page_timing.app_end = Date.now();</script>		
		        			<!-- Begin Survey scripts -->
<script src="../../JScript/foresee/foresee-trigger.js"></script>
<script src="../../JScript/foresee-variables.js"></script>
<!-- End Survey scripts -->
			
            <script>if (typeof page_timing !== 'undefined') { page_timing.metrics_start = Date.now(); }</script>
<!-- xxxxxxxxxxxxxxxxxx METRICS code begins here xxxxxxxxxxxxxxxxxxxxxxxxxxx-->
<div id="metrics">

<!-- Begin Google DAP inclusion -->
<script type="text/javascript" id="_fed_an_ua_tag" src="../../JScript/metrics/google/Universal-Federated-Analytics-Min.js@agency=HHS&amp;subagency=CDC"></script>
<!-- End Google DAP inclusion -->

<!-- Begin Template Package Custom Interactions -->
<script type="text/javascript" src="../../JScript/metrics/rd_custom_interactions.js"></script>
<!-- End Template Package Custom Interactions -->

<!-- SiteCatalyst code version: H.21. -->
<script src="../../JScript/metrics/topic_levels.js"></script>
<script src="../../JScript/metrics/s_code_v21_cdcgov.js"></script>
<script>

	enquire.register(CDC.Global.selectors.vp1, function() {
		s.prop49 = 1;
	});
	enquire.register(CDC.Global.selectors.vp2, function() {
		s.prop49 = 2;
	});
	enquire.register(CDC.Global.selectors.vp3, function() {
		s.prop49 = 3;
	});
	enquire.register(CDC.Global.selectors.vp4, function() {
		s.prop49 = 4;
	});

            
            


    s.pageName=document.title
    s.channel="STD"
    siteCatalyst.setLevel1("NCHHSTP"); 
    siteCatalyst.setLevel2("DSTDP"); 
    siteCatalyst.setLevel3("Treatment"); 
        

            
                        
            s.prop2=window.location.href;
s.prop26=document.title;
s.prop30=document.title;
s.prop31=window.location.href;
s.prop46=window.location.href;
s.server=window.location.hostname;

// Update the level variables here.
updateVariables(s);

/************* DO NOT ALTER ANYTHING BELOW THIS LINE ! **************/
var s_code=s.t();



if(s_code) {
	document.write(s_code);
}



if (document.location.protocol) {


	var cookieManagment = {
		getUuid : function (strPrefix) {
			strPrefix = strPrefix || "";
			var d = new Date();
			var seconds = Math.round(d.getTime() / 1000);
			return strPrefix + Math.floor((1 + Math.random()) * 0x10000).toString(16).substring(1) + "-" + seconds.toString();
		},
		setCookie : function (cname, cvalue, exdays, domain) {
			domain = domain || ".cdc.gov";
			var d = new Date();
			d.setTime(d.getTime() + (exdays*24*60*60*1000));
			var expires = "expires="+ d.toUTCString();
			document.cookie = cname + "=" + cvalue + ";" + expires + ";domain=" + domain + ";path=/";
		},
		getCookie : function (cname) {
			var name = cname + "=";
			var ca = document.cookie.split(';');
			var i = ca.length;
			while (i --) {
				var c = ca[i];
				while (c.charAt(0)==' ') {
					c = c.substring(1);
				}
				if (c.indexOf(name) == 0) {
					return c.substring(name.length,c.length);
				}
			}
			return "";
		},
		init : function () {



			var currCookieVal = cookieManagment.getCookie('cdc_s_vi');

			if (!currCookieVal.length || currCookieVal.indexOf('[CS]v1') != -1) {
				var newCookieVal = cookieManagment.getUuid('[CS]v2') + "-" + cookieManagment.getUuid('');
				cookieManagment.setCookie("cdc_s_vi", newCookieVal, 7);
				return newCookieVal;
			}
			return currCookieVal;
		}
	};


	var cdcSessionID = cookieManagment.init();

	s3 = s_gi("cdcgovvistorid");

	var sKey, override = {
		fun: "cdcgovvistorid",
		trackingServer: "cdc.112.2o7.net"
	};

	s3.visitorID = cdcSessionID;

	for (sKey in s) {
		if (s.hasOwnProperty(sKey)) {
			if (override.hasOwnProperty(sKey)) {
				s3[sKey] = override[sKey];

			} else {

			}
		}
	}
	updateVariables(s3);


	var s_code_uvid = s3.t();
	if(s_code_uvid) {
		document.write(s_code_uvid);
	}
}




</script>
<script type="text/javascript">
if(navigator.appVersion.indexOf('MSIE')>=0) { document.write(unescape('%3C')+'\!-'+'-'); }
</script>
<noscript><a href="http://www.omniture.com"><img src="https://smtrics.cdc.gov/b/ss/cdcgov/1/H.21--NS/01/H.21--NS/0" height="1" width="1" alt="Web Analytics" /></a></noscript><!--/DO NOT REMOVE/-->
<!-- End SiteCatalyst code version: H.21. -->
<!-- Begin Template Package DigitalGov Search Support -->
<script type="text/javascript" src="../../JScript/rd_search.js"></script>
<!-- End Template Package DigitalGov Search Support -->
</div>
<!-- xxxxxxxxxxxxxxxxxx METRICS code ends here xxxxxxxxxxxxxxxxxxxxxxxxxxx-->
<script>if (typeof page_timing !== 'undefined') { page_timing.metrics_end = Date.now(); }</script>
				

<script>
<!--//
 $(document).ready(function () {
  var cdcLeftNav = new CDC.LeftNav("nav-primary");
  cdcLeftNav.render();
 });
//-->
</script>

    	



						    </body>
	</html>
